Items where authors include "Husni, ME"
Article
Coates, LC, Soriano, ER, Corp, N et al. (42 more authors) (2022) Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA): updated treatment recommendations for psoriatic arthritis 2021. Nature Reviews Rheumatology, 18 (8). pp. 465-479. ISSN 1759-4790
Helliwell, P, Coates, LC, FitzGerald, O et al. (8 more authors) (2018) Disease-specific composite measures for psoriatic arthritis are highly responsive to a Janus kinase inhibitor treatment that targets multiple domains of disease. Arthritis Research and Therapy, 20. 242. ISSN 1478-6354
Jadon, DR, Gladman, DD, Mease, PJ et al. (19 more authors) (2017) Proceedings of the GRAPPA 2016 Retreat. The Journal of Rheumatology, 44 (5). pp. 668-673. ISSN 0315-162X
Conference or Workshop Item
Coates, LC, Soriano, E, Corp, N et al. (31 more authors) (2021) The Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) Treatment Recommendations 2021. In: EULAR 2021 Virtual Congress (Rheumatology), 02-05 Jun 2021, Virtual.
Husni, ME, Gladman, DD, Helliwell, P et al. (9 more authors) (2020) FRI0344 THE LONG-TERM EFFECT OF TREATING PSORIATIC ARTHRITIS WITH THE JANUS KINASE 1-SELECTIVE INHIBITOR FILGOTINIB ON LIPID PROFILES: AN ANALYSIS OF THE EQUATOR AND EQUATOR2 TRIALS. In: EULAR 2020, 03-06 Jun 2020, Online.
Helliwell, P, Coates, LC, FitzGerald, O et al. (8 more authors) (2018) Tofacitinib Improves Composite Endpoint Measures of Disease in Patients with Psoriatic Arthritis. In: Pan-American League of Rheumatology Associations (PANLAR) Congress 2018, 07-10 Apr 2018, Buenos Aires, Argentina.
Proceedings Paper
Merola, JF, Coates, LC, Husni, ME et al. (3 more authors) (2018) Ixekizumab reduces disease activity up to 52 weeks in active psoriatic arthritis patients with inadequate response to tumor necrosis factor inhibitors: An assessment with the use of minimal disease activity scores. In: Journal of the American Academy of Dermatology. American Academy of Dermatology 2018 Annual Meeting, 16-20 Feb 2018, San Diego, California, USA. Elsevier , AB174-AB174.